Xeris Biopharma Holdings Inc. buy Jefferies Financial Group Inc.
Start price
03.02.25
/
50%
€3.49
Target price
03.02.26
€5.81
Performance (%)
75.07%
End price
04.02.26
€6.11
Summary
This prediction ended on 04.02.26 with a price of €6.11. With a performance of 75.07% the BUY prediction by Jefferies_Financial_ was a big success. Jefferies_Financial_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Xeris Biopharma Holdings Inc. | 13.816% | 13.816% | 16.817% |
| iShares Core DAX® | 0,44 % | 5,64 % | 7,81 % |
| iShares Nasdaq 100 | 1,06 % | 0,28 % | 27,24 % |
| iShares Nikkei 225® | 1,77 % | 0,41 % | 49,27 % |
| iShares S&P 500 | 0,37 % | 1,92 % | 22,34 % |
Comments by Jefferies_Financial_ for this prediction
In the thread Xeris Biopharma Holdings Inc. diskutieren
Xeris Biopharma Holdings, Inc. (NASDAQ: XERS) had its "buy" rating re-affirmed by analysts at Jefferies Financial Group Inc.. They now have a $6.00 price target on the stock, up previously from $4.00.
Ratings data for XERS provided by MarketBeat
In the thread Trading Xeris Biopharma Holdings Inc.
Die von Jefferies_Financial_ gewählte maximale Laufzeit wurde überschritten